CTLA4 and neoplasm: In the experimental mouse studies in which different anti-mouse CTLA-4 monoclonal IgG antibodies (either natural or recombinant) with distinct Fc structures were compared, those with higher affinity to Fc-gamma receptors (FcγRs) showed the stronger Treg-depleting and anti-tumor activities [31,32].